Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Status:
Recruiting
Last Changed:
Dec 17, 2018
First Changed:
Apr 9, 2014
Disease(s):
HIV
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
Status:
Recruiting
Last Changed:
Nov 21, 2018
First Changed:
Aug 5, 2010
Disease(s):
DOCK8 Deficiency
Intervention(s):
Reduced-intensity hematopoietic stem cellFludarabine(Fludara, Berlex Laboratories)Cyclophosphamide(CTX, Cytoxan)Total Body Irradiation (TBI)Busulfan (Busulfex)Donor peripheral blood stem cell mobiliation and collectionBone Marrow Harvest Procedure

Connect. Empower. Inspire.